Birdwatch Note Rating
2024-02-13 12:56:51 UTC - NOT_HELPFUL
Rated by Participant: 90619B238A63C72ED2CADA5A4E9AF7573587F4BD0954262FBC21C6E749FD1F7F
Participant Details
Original Note:
Of a total of 64 outcomes in studies of GET, NICE graded 52 (81%) as “VERY LOW” quality and 12 (19%) as “LOW” quality. It has been established that GET is not a suitable treatment for MECFS, and a significant cohort of Long Covid patients meet MECFS diagnostic criteria. https://www.nice.org.uk/guidance/gid-ng10091/documents/evidence-review-7
All Note Details